PEspeaks

Oct 23, 2012
Pharmaceutical Executive
Just days before the reports that R&D investment in Spanish pharma had fallen to below EUR1 billion ($1.3 billion) in 2011 for the first time since 2007.
Oct 23, 2012
Pharmaceutical Executive
No doubt the November 6th election is going to be close, very close: close for the Presidency, close for the Senate, and possibly close for the House.
Oct 23, 2012
Pharmaceutical Executive
The sudden departure of EC Health Commissioner John Dalli tops an already difficult year for the European pharma regulators, writes Reflector.
Oct 18, 2012
Pharmaceutical Executive
Ethics is a matter of trust, which in the regulatory space requires transparency and openness among all stakeholders, including patients and industry.
Oct 17, 2012
Pharmaceutical Executive
Featured panelists at ExL’s annual Digital Pharma East conference this week included practicing physicians, vocal ePatients, social media gurus and digital marketing consultants with plenty of hours logged in big pharma boardrooms.
Oct 16, 2012
Pharmaceutical Executive
New stories earlier this year (1) reported that FDA scientists have been suspected of leaking confidential, commercial, and trade secret information to the media.
Oct 16, 2012
Pharmaceutical Executive
In a New York Times op-ed this week, a trio of physicians from the Memorial Sloan Kettering Cancer Center in New York announced their decision to remove an expensive new cancer treatment from the hospital formulary, citing cost-benefit as their reason.
Oct 16, 2012
Pharmaceutical Executive
FDA’s head of neurology products told industry execs at the Prix Galien Forum that the agency is open to alternative clinical trial designs in Alzheimer’s disease, and would like to see more combination products in clinical testing.
Oct 11, 2012
Pharmaceutical Executive
With Halloween candy flooding the shelves in pharmacies across the nation, it’s only appropriate that we turn the conversation toward an ever-growing drug market and therapeutic area: diabetes.
native1_300x100
lorem ipsum